We are live on ! Find out more
GYRE icon

Gyre Therapeutics
GYRE

35 hedge funds and large institutions have $13.9M invested in Gyre Therapeutics in 2015 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 3 increasing their positions, 12 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

184% more call options, than puts

Call options by funds: $71K | Put options by funds: $25K

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

10% less funds holding

Funds holding: 39 → 35 (-4)

39% less capital invested

Capital invested by funds: $22.9M → $13.9M (-$8.96M)

44% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 9

75% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 12

Holders
35
Holders Change
-4
Holders Change %
-10.26%
% of All Funds
0.92%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
5
Increased
3
Reduced
12
Closed
9
Calls
$71K
Puts
$25K
Net Calls
+$46K
Net Calls Change
-$56K

Top Buyers

1
UBS Group
UBS Group
Switzerland
+$1.25M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$107K
3
NMIMC
Northwestern Mutual Investment Management Company
Wisconsin
+$80.6K
4
Renaissance Technologies
Renaissance Technologies
New York
+$50K
5
SIM
Spark Investment Management
New York
+$18.9K

Top Sellers

1
RI
RTW Investments
New York
-$1.77M
2
CCM
Camber Capital Management
Massachusetts
-$899K
3
SCM
Sarissa Capital Management
Connecticut
-$419K
4
EC
EcoR1 Capital
California
-$261K
5
DCM
DG Capital Management
New York
-$248K
Name Holding Trade Value Shares
Change 		Change in
Stake
BJ
26
BlackRock Japan
Japan
$7K -$1.18K -3 -13%
NFA
27
Nationwide Fund Advisors
Ohio
$4K – – –
BIM
28
BlackRock Investment Management
Delaware
$3K – – –
PAM
29
Panagora Asset Management
Massachusetts
$3K – – –
TRCT
30
Tower Research Capital (TRC)
New York
$2K -$5.11K -13 -72%
BA
31
BlackRock Advisors
Delaware
$2K – – –
Manulife (Manufacturers Life Insurance)
32
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$1 – – –
RI
33
RTW Investments
New York
– -$1.77M -3,385 Closed
CCM
34
Camber Capital Management
Massachusetts
– -$899K -1,715 Closed
SCM
35
Sarissa Capital Management
Connecticut
– -$419K -800 Closed
EC
36
EcoR1 Capital
California
– -$261K -498 Closed
Fidelity Investments
37
Fidelity Investments
Massachusetts
– -$184K -350 Closed
Royal Bank of Canada
38
Royal Bank of Canada
Ontario, Canada
– -$36K -68 Closed
Bank of America
39
Bank of America
North Carolina
– -$18.9K -48 Closed
Citigroup
40
Citigroup
New York
– +$393 +1 New
1
2

GYRE Hedge Fund Activity: Q4 2015 in Review

35 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Gyre Therapeutics (GYRE) for Q4 2015, worth a combined $13.9M — down 39% from $22.9M a quarter earlier.

Sellers outnumbered buyers: 9 funds closed out of GYRE and 5 opened new positions — a net loss of 4 holders — while 12 trimmed existing stakes and 3 added.

The largest buyer was UBS Group, opening a new position worth an estimated $1.25M. The largest seller was RTW Investments, exiting entirely with an estimated $1.77M sold.

  • 35 institutional investors held Gyre Therapeutics (GYRE) as of Q4 2015, down from 39 in Q3 2015.
  • Funds reported $13.9M of Gyre Therapeutics stock for Q4 2015, down 39% quarter-over-quarter.
  • 5 funds opened new Gyre Therapeutics positions in Q4 2015 and 9 closed out, a net change of -4 holders.
  • The largest Gyre Therapeutics buyer in Q4 2015 was UBS Group, an estimated $1.25M added.
  • The largest Gyre Therapeutics seller in Q4 2015 was RTW Investments, an estimated $1.77M sold.

Based on aggregated 13F filings for Q4 2015.